1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET SNAPSHOT
3.2 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET REVENUE, 2017– 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY TYPE OF DISEASE
5.1 OVERVIEW
5.2 ACNE
5.3 ALLERGIC SKIN DISEASES
5.4 RASHES
5.5 DERMATITIS
5.6 ACTINIC KERATOSIS
5.7 OTHERS
6 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY DISTRIBUTION CHANNEL
6.1 OVERVIEW
6.2 HYPERMARKET/ SUPERMARKET
6.3 PHARMACEUTICAL STORES
6.4 ONLINE MARKET
7 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY END-USE
7.1 OVERVIEW
7.2 SKINCARE CLINICS
7.3 DERMATOLOGY MEDICATIONS CLINICS
7.4 HOSPITALS
8 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 OINTMENTS
8.3 ANTIHISTAMINES
8.4 ANTIBIOTICS
8.5 LASER THERAPY
9 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY GEOGRAPHY
9.1 NORTH AMERICA
9.1.1 MARKET DYNAMICS
9.1.1.1 DRIVERS
9.1.1.2 RESTRAINS
9.1.1.3 OPPORTUNITY
9.1.2 U.S.
9.1.3 CANADA
9.1.4 MEXICO
9.2 EUROPE
9.2.1 MARKET DYNAMICS
9.2.1.1 DRIVERS
9.2.1.2 RESTRAINS
9.2.1.3 OPPORTUNITY
9.2.2 U.K.
9.2.3 FRANCE
9.2.4 GERMANY
9.2.5 SPAIN
9.2.6 REST OF EUROPE
9.3 ASIA PACIFIC
9.3.1 MARKET DYNAMICS
9.3.1.1 DRIVERS
9.3.1.2 RESTRAINS
9.3.1.3 OPPORTUNITY
9.3.2 INDIA
9.3.3 CHINA
9.3.4 JAPAN
9.3.5 REST OF ASIA PACIFIC
9.4 MIDDLE EAST AND AFRICA
9.4.1 MARKET DYNAMICS
9.4.1.1 DRIVERS
9.4.1.2 RESTRAINS
9.4.1.3 OPPORTUNITY
9.4.2 SOUTH AFRICA
9.4.3 REST OF MIDDLE EAST AND AFRICA
9.5 LATIN AMERICA
9.5.1 MARKET DYNAMICS
9.5.1.1 DRIVERS
9.5.1.2 RESTRAINS
9.5.1.3 OPPORTUNITY
9.5.2 BRAZIL
9.5.3 REST OF LATIN AMERICA
10 COMPETATIVE LANDSCAPE
10.1 OVERVIEW
10.2 NEW PRODUCT LAUNCHES
11 GLOBAL DERMATOLOGY MEDICATIONS AND SOLUTIONS MARKET, BY COMPANY
11.1 INTRODUCTION
11.2 CELGENE CORPORATION
11.2.1 BUSINESS OVERVIEW
11.2.2 PRODUCTS & SERVICES
11.2.3 KEY STRATEGY
11.2.4 RECENT DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.3 ELI LILLY AND COMPANY
11.3.1 BUSINESS OVERVIEW
11.3.2 PRODUCTS & SERVICES
11.3.3 KEY STRATEGY
11.3.4 RECENT DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.4 GALDERMA S.A.
11.4.1 BUSINESS OVERVIEW
11.4.2 PRODUCTS & SERVICES
11.4.3 KEY STRATEGY
11.4.4 RECENT DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.5 ALMIRALL S.A.
11.5.1 BUSINESS OVERVIEW
11.5.2 PRODUCTS & SERVICES
11.5.3 KEY STRATEGY
11.5.4 RECENT DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.6 PFIZER INC.
11.6.1 BUSINESS OVERVIEW
11.6.2 PRODUCTS & SERVICES
11.6.3 KEY STRATEGY
11.6.4 RECENT DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.7 INCYTE CORPORATION
11.7.1 BUSINESS OVERVIEW
11.7.2 PRODUCTS & SERVICES
11.7.3 KEY STRATEGY
11.7.4 RECENT DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.8 GLAXOSMITHKLINE LIMITED
11.8.1 BUSINESS OVERVIEW
11.8.2 PRODUCTS & SERVICES
11.8.3 KEY STRATEGY
11.8.4 RECENT DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.9 NOVARTIS INTERNATIONAL
11.9.1 BUSINESS OVERVIEW
11.9.2 PRODUCTS & SERVICES
11.9.3 KEY STRATEGY
11.9.4 RECENT DEVELOPMENTS
11.9.5 SWOT ANALYSIS